SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061162
Filing Date
2023-11-08
Accepted
2023-11-08 16:21:38
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tnya-20230930.htm   iXBRL 10-Q 2601252
2 EX-10.1 tnya-ex10_1.htm EX-10.1 56094
3 EX-31.1 tnya-ex31_1.htm EX-31.1 23539
4 EX-31.2 tnya-ex31_2.htm EX-31.2 23659
5 EX-32.1 tnya-ex32_1.htm EX-32.1 15386
  Complete submission text file 0000950170-23-061162.txt   7984159

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnya-20230930_pre.xml EX-101.PRE 267383
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnya-20230930.xsd EX-101.SCH 42565
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnya-20230930_lab.xml EX-101.LAB 369728
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnya-20230930_cal.xml EX-101.CAL 43366
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnya-20230930_def.xml EX-101.DEF 150784
54 EXTRACTED XBRL INSTANCE DOCUMENT tnya-20230930_htm.xml XML 1318489
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40656 | Film No.: 231388213
SIC: 2836 Biological Products, (No Diagnostic Substances)